A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7436-7441

  Nekhai, Sergei ^a   Shukla, Ram R ^a   Kumar, Ajit ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA POLYMERASE II; TRANSACTIVATOR PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; TRANSACTIVATION;

EID: 0030775623     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7436-7441.1997     Document Type: Article

References (46)

1. Adams, M., L. Sharmeen, J. Kimpton, J. M. Romeo, J. V. Garcia, B. M. Peterlin, M. Groudine, and M. Emerman. 1994. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can he detected by the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. USA 91:3862-3866.
2. Antoni, B. A., S. B. Stein, and A. B. Rabson. 1994. Regulation of human immunodeficiency virus infection: implication for pathogenesis. Adv. Virus Res. 43:53-145.
3. Ascher, M. S., H. W. Sheppard, J. F. Krowka, and H. J. Bremermann. 1995. AIDS as immune system activation. Key questions that remain. Adv. Exp. Med. Biol. 374:203-210.
4. Boris-Lawrie, K. A., J. N. Brady, and A. Kumar. 1992. Sequences within the R region of the long terminal repeat activate basal transcription from the HIV-1 promoter. Gene Expr. 2:215-230.
5. Bukrinsky, M. I., T. L. Stanwick. M. P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423-427.
6. Chodosh, L. A., A. Fire, M. Samuels, and P. A. Sharp. 1989. 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J. Biol. Chem. 264:2250-2257.
7. Cisek, L. J., and J. L. Corden. 1991. Purification of protein kinases that phosphorylate the repetitive carboxyl-terminal domain of eukaryotic RNA polymerase II. Methods Enzymol. 200:301-325.
8. Corden, J. L., D. L. Cadena, J. M. Ahearn, Jr., and M. E. Dahmus. 1985. A unique structure at the carboxyl terminus of the largest subunit of eukaryotic RNA polymerase II. Proc. Natl. Acad. Sci. USA 82:7934-7938.
9. Dahmus, M. E. 1995. Phosphorylation of the C-terminal domain of RNA polymerase II. Biochim. Biophys. Acta 1261:171-182.
10. Feaver, W. J., J. Q. Svejstrup, N. L. Henry, and R. D. Kornberg. 1994. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIH. Cell 79:1103-1109.
11. Feinberg, M. B., D. Baltimore, and A. D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045-4049.
12. Fisher, R. P., and D. O. Morgan. 1994. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78:713-724.
13. Fisher, R. P., P. Jin, H. M. Chamberlin, and D. O. Morgan. 1995. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83:47-57.
14. Folks, T., J. Kelly, S. Benn, A. Kinter, J. Justement, and J. Gold. 1986. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J. Immunol. 136:4049-4053.
15. Garcia-Martinez, L. F., G. Mavankal, J. M. Neveu, W. S. Lane, D. Ivanov, and R. B. Gaynor. 1997. Purification of a Tat-associatcd kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:2836-2850.
16. Green, M., and P. M. Loewenstein. 1988. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55:1179-1188.
17. Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1612-1620.
18. Herrmann, C. H., M. O. Gold, and A. P. Rice. 1996. Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain. Nucleic Acids Res. 24:501-508.
19. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
20. Kashanchi, F., S. N. Khleif, J. F. Duvall, M. R. Sadaie, M. F. Radonovich, M. Cho, M. A. Martin, S.-Y. Chen, R. Weinmann, and J. N. Brady. 1996. Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Drl and stabilizes the TFIID-TFIIA complex. J. Virol. 70:5503-5510.
21. Kashanchi, F., G. Piras, M. F. Radonovich, J. F. Duvall, A. Fattaey, C. M. Chiang, R. G. Roeder, and J. N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature (London) 367:295-299.
22. Kato, H., H. Sumimoto, P. Pognonec, C.-H. Chen, C. A. Rosen, and R. G. Roeder. 1992. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:655-666.
23. Keen, N. J., M. J. Gait, and J. Karn. 1996. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. USA 93:2505-2510.
24. Kumar, A., S. Nekhai, R. R. Shukla, A. Fernandez, and N. Lamb. Transactivation of HIV-1 promoter by Tat is induced by a Tat-associatcd RNA polymerase II carboxy-terminal domain kinase. Unpublished data.
25. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292.
26. Laybourn, P. J., and M. E. Dahmus. 1989. Transcription-dependent structural changes in the C-terminal domain of mammalian RNA polymerase subunit IIa/o. J. Biol. Chem. 264:6693-6698.
27. Laybourn, P. J., and M. E. Dahmus. 1990. Phosphorylation of RNA polymerase IIA occurs subsequent to interaction with the promoter and before the initiation of transcription. J. Biol. Chem. 265:13165-13117.
28. Marciniak, R. A., and P. A. Sharp. 1991. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:4189-4196.
29. Mavankal, G., O. S. H. Ignatius, H. Oliver, D. Sigman, and R. B. Gaynor. 1996. Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II. Proc. Natl. Acad. Sci. USA 93:2089-2094.
30. McKnight, S. L. 1996. Transcription revisited: a commentary of the 1995 Cold Spring Harbor Laboratory meeting, a mechanism of eukaryotic transcription. Genes Dev. 10:367-371.
31. O'Brien, T., S. Hardin, A. Greenleaf, and J. T. Lis. 1994. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature (London) 370:75-77.
32. Parada, C. A., and R. G. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature (London) 384:375-378.
33. Peterson, S. R., A. Dvir, C. W. Anderson, and W. S. Dynan. 1992. DNA binding provides a signal for phosphorylation of the RNA polymerase II heptapeptide repeats. Genes Dev. 6:426-438.
34. Rosenblatt, J., H. De Bondt, J. Jancarik, D. O. Morgan, and S.-H. Kim. 1993. Purification and crystallization of human cyclin-dependent kinase 2. J. Mol. Biol. 230:1317-1319.
35. Rothblum, C. J., J. Jackman, J. Mikovits, R. R. Shukla, and A. Kumar. 1995. Interaction of nuclear protein p140 with human immunodeficiency virus type 1 TAR RNA in mitogen-activated primary human T lymphocytes. J. Virol. 69:5156-5163.
36. Roy, R., J. P. Adamczewski, T. Seroz, W. Vermeulen, J. P. Tassan, L. Schaeffer, E. A. Nigg, J. H. Hoeijmakers, and J.-M. Egly. 1994. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79:1093-1101.
37. Seigel, L. J., W. G. Nash, B. J. Poiesz, J. L. Moore, and S. J. O'Brien. 1986. Dynamic and nonspecific dispersal of human T-cell leukemia/lymphoma virus type-I integration in cultured lymphoma cells. Virology 154:67-75.
38. Serizawa, H., T. P. Makela, J. W. Conaway, R. C. Conaway, R. A. Weinberg, and R. A. Young. 1995. Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature (London) 374:280-282.
39. Shiekhattar, R., F. Mermelstein, R. P. Fisher, R. Drapkin, B. Dynlacht, H. C. Wessling, D. O. Morgan, and D. Reinberg. 1995. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature (London) 374:283-287.
40. Tassan, J.-P., M. Jaquenoud, A. M. Fry, S. Frutiger, G. J. Hughes, and E. A. Nigg. 1995. In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO J. 14:5608-5617.
41. Wu-Baer, F., D. Sigman, and R. B. Gaynor. 1995. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. Proc. Natl. Acad. Sci. USA 92:7153-7157.
42. Yankulov, K., K. Yamashita, R. Roy, J.-M. Egly, and D. L. Bentley. 1995. D-Ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J. Biol. Chem. 270:23922-23925.
43. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
44. Zawel, L., and D. Reinberg. 1995. Common themes in assembly and function of eukaryotic transcription complexes. Annu. Rev. Biochem. 64:533-561.
45. Zhou, Q., and P. A. Sharp. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14;321-328.
46. Zhou, Q., and P. A. Sharp. 1996. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274:605-610.